skip to content

Cambridge Immunology Network


Molecular and structural techniques are used to address a wide range of immunological problems

Cambridge has a strong tradition in molecular biology with the techniques of molecular biology having been rapidly applied to problems of immunological interest. This began with Rodney Porter’s initial studies in the Department of Biochemistry on the structure of IgG and Cesar Milstein's work at MRC-LMB on the nature of antibody diversity, both using protein chemical techniques developed by their mentor Fred Sanger. Work on the molecular mechanisms involved in the generation of antigen receptor diversity, as well as in the field of antibody engineering, continue at MRC-LMB, Babraham and the Department of Pathology. Molecular and structural techniques have, however, been exploited to approach a much wider range of immunological problems including gene expression, signalling, haematopoiesis, antigen presentation, infection, innate immunity, lymphoid malignancies and autoimmunity - underpinning programmes at nearly all the sites in Cambridge where research is carried out in immunobiology. Protein structural analysis is particularly strong at the MRC-LMB and CIMR, for example.

Dr Rachael  Bashford-Rogers
Group Leader
Wellcome Trust Centre for Human Genetics
University of Oxford
Dr Keith  Boyle
Senior Research Scientist
Dr Louise  Boyle
Wellcome Trust Senior Research Fellow
Reader in Molecular Immunology
Research Associate
Dr Mike R Clark
Retired (30th September 2014) as Reader in Therapeutic and Molecular Immunology
Dr Janet  Deane
Royal Society University Research Fellow
Deputy Director Wellcome Trust 4-year PhD Prog in Infection & Immunity
Stephen Graham
Professor of Virus:Host Interactions
Professor Gillian M Griffiths
Director of Cambridge Institute for Medical Research
Dr John  James
Sir Henry Dale Fellow (Wellcome Trust)
Professor Yorgo  Modis
Wellcome Trust Senior Research Fellow
Dr James  Nathan
Wellcome Trust Senior Clinical Fellow